Loomis, Sayles & Company
FPRX

Loomis, Sayles & Company’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Loomis, Sayles & Company’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-130
Closed -$7K – 1059
2016
Q4 		$7K Hold
130
– – ﹤0.01% 879
2016
Q3 		$7K Hold
130
– – ﹤0.01% 837
2016
Q2 		$5K Buy
+130
New +$5K ﹤0.01% 858